The miRNA hsa-miR-195–5p has been proven to be a critical regulator in the progression of prostate cancer, which inhibits cell proliferation by downregulating proline-rich protein 11 expression (Cai et al., 2018). This evidence concerns the gene PRR11 and prostate carcinoma.